Stocktoria
PTC THERAPEUTICS, INC. PTCT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-06-20
PTC THERAPEUTICS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 50.1% | -37.5% | -46.9% | -64.0% | -69.5% |
| Net margin | 39.4% | -45.0% | -66.8% | -80.0% | -97.3% |
| FCF margin | 40.6% | -14.2% | -19.9% | -55.6% | -51.9% |
| Return on assets | 23.5% | -21.3% | -33.1% | -32.8% | -27.0% |
| Return on equity | -332.5% | 33.1% | 76.6% | 161.1% | -36432.6% |
| Debt / equity | — | -0.26× | -0.35× | -1.65× | 196.03× |
| Current ratio | 2.35 | 2.35 | 2.02 | 1.71 | 1.87 |
| Revenue growth | 114.5% | -14.0% | 34.2% | 29.7% | 41.4% |
Source: SEC EDGAR filings · CIK 0001070081 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.